The fastest scan of today’s most useful stories.
Scientists have made a groundbreaking discovery, finding compelling evidence that dinosaur fossils can still contain traces of their original proteins, directly challenging the long-held belief that fossilization completely destroys all organic material. This revolutionary finding promises to transform the study of ancient life, offering unprecedented insights into dinosaur biology and their evolutionary paths.
Japanese researchers have unearthed compelling evidence of a powerful solar storm around 1200 CE, identified through ancient tree rings and historical accounts of vivid red auroras. This 800-year-old "red sky" event reveals a highly active Sun with unusually short solar cycles, offering crucial insights for safeguarding future Moon missions from similar radiation.
The CDC has reported a grim milestone, revealing suicide is now a top 10 cause of death in the U.S., with nearly 49,000 Americans dying by suicide in 2024 alone. This alarming surge, linked to rising mental health conditions, has prompted calls for mandatory suicide risk screening during all healthcare visits to identify and help at-risk individuals.
Columbia University researchers have finally solved the perplexing climate mystery of why Earth's upper atmosphere is cooling while its surface heats up. They discovered that at higher altitudes, carbon dioxide behaves differently, radiating heat directly into space and accelerating cooling in the stratosphere.
New Jersey, home to the nation's highest number of Superfund sites, faces a critical threat to environmental cleanup as federal budget cuts loom for the EPA. A proposed 47% reduction in Superfund Program appropriations, coupled with decreased staffing, could severely stall progress on contaminated sites across the state.
A groundbreaking new drug, daraxonrasib, is showing incredible promise in substantially extending the lives of pancreatic cancer patients by targeting specific cellular proteins that fuel cancer growth. This innovative treatment, which could also impact lung and colon cancers, is currently on fast-track FDA review and might be approved later this year, offering a beacon of hope.
